Company: PHR
Filing Date: 2025-12-09
Form Type: 10-Q
Source: 0001412408-25-000132
Chunk: 115

Company: Phreesia, Inc.
Filing Date: 2025-12-09
Form: 10-Q
Item: Part I, Item 1
Chunk 115
---
PSUs188,676 — 447,142 — Liability awards56,904 — 110,589 — ESPP— — 12,487 — Weighted-average shares of common stock outstanding, diluted61,559,849 57,891,591 61,491,761 57,358,637 Diluted net income (loss) per share attributable to common stockholders:$0.07 $(0.25)$0.02 $(0.91)(b) Potential dilutive securitiesThe Company excludes potential dilutive securities, which include stock options, RSUs, PSUs, liability awards and grants under the Company's ESPP from the computation of diluted net income (loss) per share when the effect of including the securities would be anti-dilutive. The following potential shares of common stock, presented based on amounts outstanding at each period end, were excluded from the calculation of diluted net income (loss) per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect:Three months endedOctober 31,Nine months endedOctober 31,2025202420252024Stock options to purchase common stock, restricted stock and performance stock awards322,639 6,642,857 1,691,475 6,642,857 Employee stock purchase plan64,749 82,784 64,749 82,784 Total387,388 6,725,641 1,756,224 6,725,641 

14. Related party transactions

For the three months ended October 31, 2025 and 2024, the Company recognized revenue totaling $301 and $326, respectively, for advertisements placed by a pharmaceutical company. For the nine months ended October 31, 2025 and 2024, the Company recognized revenue totaling $762 and $997, respectively, for advertisements placed by the 

33

same pharmaceutical company. One of the Company's independent members of its board of directors serves on the board of directors for this pharmaceutical company. As of October 31, 2025 and January 31, 2025, accounts receivable from the pharmaceutical company totaled $361 and $116, respectively.

15. Segments and geographic information

Operating segments are defined as components of an enterprise about which separate financial information is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance. The Company defines the